Pacira BioSciences, Inc. Income Statement

1Y3Y5Y7Y10YAll
Download Data
Income Statement Dec2009 Dec2010 Dec2011 Dec2012 Dec2013 Dec2014 Dec2015 Dec2016 Dec2017 Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Revenue & cost
Revenue 15.01M14.56M15.69M39.08M85.55M197.67M249.00M276.37M0.40M337.28M421.03M429.65M541.53M666.82M674.98M700.97M
Cost of Revenue 16.74M32.14M54.77M77.44M71.84M110.10M87.92M86.84M106.71M117.33M140.25M199.29M184.67M170.43M
Gross Profit -1.05M6.95M30.78M120.23M177.16M166.27M-87.52M250.43M314.31M312.32M401.28M467.53M490.31M530.54M
Operating items
Amortization - Intangibles 5.70M7.87M13.55M57.29M57.30M57.30M
Research & Development 26.23M18.63M14.87M9.94M21.56M18.73M28.66M45.68M57.29M55.69M72.12M59.42M55.55M84.80M76.26M81.58M
Selling, General & Administrative 5.02M6.37M20.16M46.31M62.51M106.66M139.04M152.61M161.49M177.26M200.78M193.52M199.34M254.52M269.44M294.10M
Restructuring Costs -42.91M10.90M-0.35M7.70M
Other Operating Expenses 12.30M12.28M19.76M32.14M54.77M77.44M71.84M110.10M92.78M88.41M137.65M130.36M239.63M256.58M241.96M390.96M
Operating Expenses 43.55M37.27M54.79M88.38M138.84M202.83M239.54M308.39M311.57M321.36M410.55M383.30M451.61M606.80M587.30M774.34M
Operating Income -28.55M-22.71M-39.10M-49.30M-53.29M-5.17M9.46M-32.02M-24.94M15.91M10.48M46.35M89.92M60.02M87.67M-73.37M
EBIT -28.55M-22.71M-39.10M-49.30M-53.29M-5.17M9.46M-32.02M-24.94M15.91M10.48M46.35M89.92M60.02M87.67M-73.37M
Non-operating items
Interest & Investment Income 0.08M0.15M0.26M0.28M0.26M0.38M0.68M1.32M4.08M6.50M7.38M4.63M0.90M4.54M11.44M19.69M
Other Non Operating Income 0.37M0.49M0.07M-1.06M-3.40M-0.16M-0.17M-0.08M-3.73M-0.89M-4.98M-8.07M-2.67M-11.29M-16.93M7.52M
Non Operating Income -3.16M-4.44M-4.23M-2.98M-11.06M-8.38M-7.33M-5.82M-17.53M-16.34M-21.23M-26.26M-33.52M-11.29M-0.19M-0.37M
Net income details
EBT -30.19M-26.52M-43.33M-52.28M-64.35M-13.54M2.12M-37.84M-42.47M-0.42M-10.75M20.09M56.40M13.30M61.70M-63.11M
Tax Provisions -0.44M0.17M0.26M0.10M0.14M0.05M0.27M-125.43M14.42M-2.61M19.75M36.45M
Profit After Tax -31.71M-27.15M-43.33M-52.28M-63.91M-13.72M1.86M-37.95M-42.61M-0.47M-11.02M145.52M41.98M15.91M41.95M-99.56M
Income from Continuing Operations -30.19M-26.52M-43.33M-52.28M-63.91M-13.72M1.86M-37.95M-42.61M-0.47M-11.02M145.52M41.98M15.91M41.95M-99.56M
Consolidated Net Income -30.19M-26.52M-43.33M-52.28M-63.91M-13.72M1.86M-37.95M-42.61M-0.47M-11.02M145.52M41.98M15.91M41.95M-99.56M
Income towards Parent Company -30.19M-26.52M-43.33M-52.28M-63.91M-13.72M1.86M-37.95M-42.61M-0.47M-11.02M145.52M41.98M15.91M41.95M-99.56M
Net Income towards Common Stockholders -30.19M-26.52M-43.33M-52.28M-63.91M-13.72M1.86M-37.95M-42.61M-0.47M-11.02M145.52M41.98M15.91M41.95M-99.56M
Additional items
EPS (Basic) -55.32-47.29-2.64-1.72-1.93-0.390.05-1.02-1.07-0.01-0.273.410.950.350.91-2.15
EPS (Weighted Average and Diluted) -2.64-1.93-0.390.04-1.02-1.07-0.01-0.273.330.920.340.89-2.15
Shares Outstanding (Weighted Average) 17.23M17.23M17.23M32.55M33.54M36.06M36.76M37.40M40.57M41.11M41.73M43.44M44.54M45.88M46.44M46.17M
Shares Outstanding (Diluted Average) 16.44M33.18M35.30M41.30M37.24M39.81M40.91M41.51M43.68M45.63M46.54M51.98M46.24M
EBITDA -28.55M-22.71M-39.10M-49.30M-53.29M-5.17M9.46M-32.02M-24.94M15.91M10.48M46.35M89.92M60.02M87.67M-73.37M
Interest Expenses 1.72M3.96M4.78M1.81M7.25M8.28M7.72M7.06M18.05M21.95M23.63M25.67M31.75M39.98M20.31M16.57M
Tax Rate 0.69%12.45%25.57%32.00%